BULLFROG AI HOLDINGS, INC. Earnings Per Share (Basic)
BULLFROG AI HOLDINGS, INC. (BFRG) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.12.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.13.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.15.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$0.63.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$0.85.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$0.89.
- BULLFROG AI HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$0.70.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-14 | -$0.19 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.63 10-K · filed 2026-03-19 |
| 2025-09-30 | -$0.15 10-Q · filed 2025-11-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.51 10-Q · filed 2025-11-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$0.15 10-Q · filed 2026-08-14 | -$0.36 10-Q · filed 2026-08-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-05-14 |
| 2024-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.85 10-K · filed 2026-03-19 |
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-14 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.67 10-Q · filed 2025-11-14 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-11-14 |
| 2024-06-30 | -$0.20 10-Q · filed 2025-08-13 | -$0.46 10-Q · filed 2025-08-13 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-08-13 |
| 2024-03-31 | -$0.26 10-Q · filed 2025-05-13 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-05-13 |
| 2023-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-03-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-03-14 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-03-14 | -$0.89 10-K · filed 2025-03-14 |
| 2023-09-30 | -$0.21 10-Q · filed 2024-11-08 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$0.72 10-Q · filed 2024-11-08 | |
| 2023-06-30 | -$0.24 10-Q · filed 2024-08-07 | -$0.51 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$0.70 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$0.16 10-Q · filed 2023-11-14 | -$0.45 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$0.17 10-Q · filed 2023-08-14 | -$0.29 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.12 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | -$14.00 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |